Corcept Therapeutics
CORT
#1631
Rank
HK$102.80 B
Marketcap
HK$951.00
Share price
2.24%
Change (1 day)
65.23%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2026 (TTM): HK$4.05

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is HK$4.08. In 2025 the company made an earnings per share (EPS) of HK$7.38 a decrease over its 2024 EPS that were of HK$10.59.

EPS history for Corcept Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$4.05-45.05%
2025HK$7.38-30.37%
2024HK$10.59
2022HK$7.45-2.06%
2021HK$7.615.43%
2020HK$7.2210.84%
2019HK$6.5127.69%
2018HK$5.10-42.48%
2017HK$8.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.54 1,579.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$52.26 1,180.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96 46.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$234.50 5,646.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$9.93 143.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.63 773.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-HK$1.02-125.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-HK$0.16-103.85%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$2.98-26.92%๐Ÿ‡บ๐Ÿ‡ธ USA